October 25th 2024
Farrukh Awan, MD, discuses the evolving role of bispecific antibodies in the treatment paradigm of diffuse large B-cell lymphoma.
March 7th 2023
Farrukh Awan, MD, discusses the potential use of BTK inhibitors in the management of mantle cell leukemia.
November 7th 2022
Farrukh Awan, MD, discusses the current use of BTK inhibitors in the management of chronic lymphocytic leukemia and important factors to consider when determining the best treatment strategy.
October 18th 2022
Farrukh Awan, MD, discusses the evolution of treating frontline chronic lymphocytic leukemia.
November 17th 2020
Farrukh Awan, MD, discusses the importance of risk stratification in chronic lymphocytic leukemia.
October 23rd 2020
Farrukh Awan, MD, discusses treatment options in the first relapsed setting in patients with chronic lymphocytic leukemia.
May 2nd 2020
Farrukh Awan, MD, discusses remaining questions regarding the use of BTK inhibitors and CD20-directed monoclonal antibodies in chronic lymphocytic leukemia.
April 8th 2020
Farrukh Awan, MD, discusses questions regarding combination therapies in chronic lymphocytic leukemia.
April 2nd 2020
Farrukh Awan, MD, discusses novel approaches under investigation in relapsed/refractory chronic lymphocytic leukemia.
March 6th 2020
Farrukh Awan, MD, discusses the utilization of acalabrutinib in patients with chronic lymphocytic leukemia.
February 14th 2020
Farrukh Awan, MD, discusses the need for time-limited treatments in patients with chronic lymphocytic leukemia.
February 5th 2020
Farrukh Awan, MD, discusses the role of chemotherapy in the treatment of patients with chronic lymphocytic leukemia (CLL).